- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/68 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
Patent holdings for IPC class A61K 47/68
Total number of patents in this class: 12663
10-year publication summary
|
234
|
473
|
831
|
1002
|
962
|
1138
|
1187
|
1317
|
1508
|
1458
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| SeaGen Inc | 594 |
261 |
| Regeneron Pharmaceuticals, Inc. | 4417 |
211 |
| Daiichi Sankyo Company, Limited | 1879 |
209 |
| Genentech, Inc. | 4006 |
193 |
| MedImmune Limited | 627 |
152 |
| Hanmi Pharm. Co., Ltd. | 576 |
149 |
| Dyne Therapeutics, Inc. | 252 |
138 |
| ImmunoGen, Inc. | 403 |
135 |
| The Regents of the University of California | 20245 |
115 |
| Bristol-myers Squibb Company | 4833 |
95 |
| Novartis AG | 10635 |
92 |
| Bolt Biotherapeutics, Inc. | 119 |
89 |
| Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 309 |
86 |
| Pfizer Inc. | 3403 |
78 |
| Zymeworks Inc. | 263 |
67 |
| ADC Therapeutics SA | 123 |
66 |
| Hoffmann-La Roche Inc. | 3523 |
65 |
| Avidity Biosciences, Inc. | 178 |
65 |
| Memorial Sloan-Kettering Cancer Center | 1975 |
63 |
| Yale University | 2436 |
62 |
| Other owners | 10272 |